Chronic diseases impact the productivity and quality of life of many individuals and represent a large portion of health care spending. New approaches are needed to improve both the effectiveness and the efficiency of caring for chronically ill patients.
Improved health outcomes are possible when comprehensive and timely biological assessments are combined with tools that proactively engage patients, clinicians, and caregivers in the management of disease. ProterixBio is developing innovative products to transform the management of chronic diseases. Our initial focus is Chronic Obstructive Pulmonary Disease (COPD).
Billerica, MA, September 13, 2016 – ProterixBio, Inc. today announced that it has joined the Industrial Advisory boards of the COPD (chronic obstructive pulmonary disease) Foundation and the SPIROMICS Consortium.…
Read MoreProterixBio, Inc. will be attending Biotech Showcase™ 2017, to be held January 9-11th at the Hilton San Francisco Union Square. Biotech Showcase™ 2017 is one of the industry's largest…
Read More